162 related articles for article (PubMed ID: 33912836)
21. Pharmaceutical interventions in the emergency department: cost-effectiveness and cost-benefit analysis.
Miarons M; Marín S; Amenós I; Campins L; Rovira M; Daza M
Eur J Hosp Pharm; 2021 May; 28(3):133-138. PubMed ID: 35049519
[TBL] [Abstract][Full Text] [Related]
22. Scoping Review of Interventions Associated with Cost Avoidance Able to Be Performed in the Intensive Care Unit and Emergency Department.
Hammond DA; Gurnani PK; Flannery AH; Smetana KS; Westrick JC; Lat I; Rech MA
Pharmacotherapy; 2019 Mar; 39(3):215-231. PubMed ID: 30664269
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
24. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
25. The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilization.
Pevnick JM; Keller MS; Kennelty KA; Nuckols TK; Ko EM; Amer K; Anderson L; Armbruster C; Conti N; Fanikos J; Guan J; Knight E; Leang DW; Llamas-Sandoval R; Matta L; Moriarty D; Murry LT; Muske AM; Nguyen AT; Phung E; Rosen O; Rosen SL; Salandanan A; Shane R; Schnipper JL
Contemp Clin Trials; 2021 Jul; 106():106419. PubMed ID: 33932574
[TBL] [Abstract][Full Text] [Related]
26. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
[TBL] [Abstract][Full Text] [Related]
27. Clinical, Economic, and Organizational Impact of the Clinical Pharmacist in an Orthopedic and Trauma Surgery Department.
Renaudin P; Coste A; Audurier Y; Berbis J; Canovas F; Jalabert A; Castet-Nicolas A; Mercier G; Villiet M; Dagneaux L; Breuker C
J Patient Saf; 2021 Dec; 17(8):e1507-e1513. PubMed ID: 30365407
[TBL] [Abstract][Full Text] [Related]
28. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
Gallagher J; Byrne S; Woods N; Lynch D; McCarthy S
BMC Health Serv Res; 2014 Apr; 14():177. PubMed ID: 24742158
[TBL] [Abstract][Full Text] [Related]
29. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
30. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.
Houso A; Hamdan M; Falana H
Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501
[TBL] [Abstract][Full Text] [Related]
31. Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital.
Gunterus A; Lopchuk S; Dunn C; Floyd R; Normandin B
Ment Health Clin; 2016 Sep; 6(5):242-247. PubMed ID: 29955477
[TBL] [Abstract][Full Text] [Related]
32. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
Chen PZ; Wu CC; Huang CF
J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
[TBL] [Abstract][Full Text] [Related]
33. Effect of pharmacists' clinical interventions on nonformulary drug use.
Packer LA; Mahoney CD; Rich DS; Jeffrey LP
Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
[TBL] [Abstract][Full Text] [Related]
34. Clinical and economic impact of medication reconciliation by designated ward pharmacists in a hospitalist-managed acute medical unit.
Park B; Baek A; Kim Y; Suh Y; Lee J; Lee E; Lee JY; Lee E; Lee J; Park HS; Kim ES; Lim Y; Kim NH; Ohn JH; Kim HW
Res Social Adm Pharm; 2022 Apr; 18(4):2683-2690. PubMed ID: 34148853
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
36. Economic impact of pharmacist interventions in pediatric ambulatory care clinics.
Yung E; McNicol M; Lewis D; Fischer J; Petkus K; Sebastian S; Abdel-Rasoul M; Schmuhl K; Wise K
J Am Pharm Assoc (2003); 2021; 61(2):198-205.e1. PubMed ID: 33358098
[TBL] [Abstract][Full Text] [Related]
37. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
[TBL] [Abstract][Full Text] [Related]
38. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
[TBL] [Abstract][Full Text] [Related]
39. Roles of the emergency medicine pharmacist: A systematic review.
Roman C; Edwards G; Dooley M; Mitra B
Am J Health Syst Pharm; 2018 Jun; 75(11):796-806. PubMed ID: 29802113
[TBL] [Abstract][Full Text] [Related]
40. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
